Blog
RSS FeedPosted by Michael Wonder on 05 Dec 2019
Decision to widen access to bortezomib for multiple myeloma and AL amyloidosis
5 December 2019 - PHARMAC is pleased to announce a decision to widen access to bortezomib for patients with multiple ...
Posted by Michael Wonder on 05 Dec 2019
Decision to fund two new cancer treatments: olaparib and fulvestrant
5 December 2019 - PHARMAC is pleased to announce a decision to fund two new cancer treatments and amend the ...
Posted by Michael Wonder on 03 Dec 2019
Cancer Control Agency open, Prime Minister hails Blair Vining's 'tireless advocacy'
3 December 2019 - The Prime Minister has acknowledged Blair Vining's "tireless advocacy" as the new independent Cancer Control Agency ...
Posted by Michael Wonder on 03 Dec 2019
Patient advocacy group demands doubling of PHARMAC budget to fund life-saving treatments
3 December 2019 - A group of patient advocates are calling for PHARMAC's billion-dollar budget to be doubled so it ...
Posted by Michael Wonder on 01 Dec 2019
New Zealand Pharmaceutical Schedule - 1 December 2019 update
1 December 2019 - The December 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Nov 2019
Changes to wastage funding
27 November 2019 - PHARMAC is seeking feedback on a proposal relating to how it funds discarded medicines (“wastage”) in ...
Posted by Michael Wonder on 20 Nov 2019
Auckland widow's wish to give away leftover cancer medication illegal under Medicines Act
20 November 2019 - An Auckland widow who spoke out about New Zealand's drug wastage after her husband's death will ...
Posted by Michael Wonder on 19 Nov 2019
Epilepsy sufferer says victims of PHARMAC drug switch should be compensated
19 November 2019 - An epilepsy sufferer who urged others to boycott the Government's change in anti-epileptic drug medication is ...
Posted by Michael Wonder on 18 Nov 2019
Nancy Brunning's death: calls for PHARMAC reform
18 November 2019 - There are calls for PHARMAC to be reformed after the death of actress Nancy Brunning. ...
Posted by Michael Wonder on 15 Nov 2019
PHARMAC backs down on epilepsy drug brand switch
15 November 2019 - PHARMAC has backed down on a controversial drug brand switch affecting patients with epilepsy and mental ...
Posted by Michael Wonder on 15 Nov 2019
PHARMAC to widen access to the exceptional circumstances process for lamotrigine
15 November 2019 - Patients taking lamotrigine who have concerns about the change can talk with their doctor about remaining ...
Posted by Michael Wonder on 14 Nov 2019
Epilepsy patients 'terrified' after PHARMAC switches funding
14 November 2019 - An epilepsy patient who's been forced to change medication says she's 'terrified'. ...
Posted by Michael Wonder on 13 Nov 2019
Epilepsy NZ calls for halt to drug switch following deaths of three people
13 November 2019 - Epilepsy New Zealand is urging authorities to immediately halt a drug switch following the death of ...
Posted by Michael Wonder on 12 Nov 2019
Lung cancer ALK+NSCLC genetic mutation screening could save lives - doctors
12 November 2019 - Lives are being needlessly cut short because there's no universal testing for a type of lung ...
Posted by Michael Wonder on 12 Nov 2019
Three deaths following epilepsy drug brand switch
12 November 2019 - Three deaths have been reported to the Centre for Adverse Reactions Monitoring after PHARMAC forced patients ...